A detailed history of New Century Financial Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, New Century Financial Group, LLC holds 9,400 shares of AZN stock, worth $624,160. This represents 0.27% of its overall portfolio holdings.

Number of Shares
9,400
Previous 4,600 104.35%
Holding current value
$624,160
Previous $359 Million 104.14%
% of portfolio
0.27%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$76.67 - $87.62 $368,016 - $420,576
4,800 Added 104.35%
9,400 $732 Million
Q2 2024

Aug 27, 2024

SELL
$66.81 - $80.83 $36,879 - $44,618
-552 Reduced 10.71%
4,600 $359 Million
Q1 2024

Apr 19, 2024

SELL
$61.03 - $69.57 $58,893 - $67,135
-965 Reduced 15.78%
5,152 $349 Million
Q4 2023

Feb 08, 2024

BUY
$61.89 - $69.28 $378,581 - $423,785
6,117 New
6,117 $412 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track New Century Financial Group, LLC Portfolio

Follow New Century Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Century Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Century Financial Group, LLC with notifications on news.